Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: J Psychosoc Oncol. 2016 Aug 5;34(6):449–459. doi: 10.1080/07347332.2016.1217963

Table 1.

Participant demographic information (patients, siblings, and comparison between groups).

Patient campers
(n = 1,230)
n (%)
Sibling campers
(n = 884)
n (%)
χ2 p
Gender Male 581 (47.4) 488 (55.3) 1.5 0.23
Female 645 (52.6) 395 (44.7)
Cancer treatmenta On-treatment 202 (16.9) 197 (23.2) 12.3 <0.001
Not on-treatment 991 (83.1) 653 (76.8)
Cancer relapsea Cancer relapsed 123 (10.9) 143 (18.1) 19.9 <0.001
Cancer did not relapse 1,003 (89.1) 648 (81.9)
Camp experience First-year attending camp 254 (20.9) 216 (24.8) 4.3 0.04
Returning camper 963 (79.1) 659 (75.3)
     Camp model Oncology patients only 789 (64.1) n/a Not compared due to different applicable models
Siblings only n/a 476 (53.8)
Oncology patients and siblings 432 (35.1) 397 (44.9)
Family camp 9 (0.7) 11 (1.2)
Camper’s sibling also attended campb Yes 278 (22.8) 604 (69.2) 449.8 <0.001
No 941 (77.2) 269 (30.8)
Bereaved sibling n/a 125 (14.7) n/a
Mean (SD) Mean (SD) t p

Age (years) 12.9 (3.1) 12.0 (2.8) −7.1 <0.001
Number of years camp attended 3.3 (2.9) 2.9 (2.7) −3.3 <0.001
a

Siblings were asked to report on their brother/sister with cancer’s current treatment and relapse status.

b

Sibling attended camp at the same time as the respondent.